NYSE:TARO

Taro Pharmaceutical Industries Earnings Date, Estimates, & History

$63.99

+0.19 (+0.30 %)

(As of 09/24/2021 12:00 AM ET)

Add

Compare

Today's Range

$63.28

▼

$64.27

50-Day Range

$62.34

▼

$73.38

52-Week Range

$53.95

▼

$80.00

Volume16,129 shs

Average Volume24,402 shs

Market Capitalization$2.43 billion

P/E Ratio84.20

Dividend YieldN/A

Beta0.93

Upcoming
Earnings Date
Oct. 27
Estimated

Actual EPS
(Jul. 27)
$1.09
Beat By $0.25

Consensus EPS
(Jul. 27)
$0.84

Last Year's Q3 EPS
(7/29/2020)
-$11.37

Earnings Per Share Revenue

Taro Pharmaceutical Industries Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Taro Pharmaceutical Industries Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Taro Pharmaceutical Industries (NYSE:TARO) Earnings Estimates

Current Year EPS Consensus Estimate: $4.21 EPS
Next Year EPS Consensus Estimate: $4.55 EPS

TARO Earnings Information

Taro Pharmaceutical Industries last posted its earnings data on July 27th, 2021. The reported $1.09 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.25. The business had revenue of $147.11 million for the quarter, compared to analyst estimates of $137.20 million. Taro Pharmaceutical Industries has generated $3.70 earnings per share over the last year ($0.76 diluted earnings per share) and currently has a price-to-earnings ratio of 84.2. Earnings for Taro Pharmaceutical Industries are expected to grow by 8.08% in the coming year, from $4.21 to $4.55 per share. Taro Pharmaceutical Industries has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 27th, 2021 based off prior year's report dates.

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
10/27/2021 (Estimated)
7/27/2021	6/30/2021	$0.84	$1.09	+$0.25	$2.68	$137.20 million	$147.11 million
5/18/2021	Q4	$0.92	($0.78)	($1.70)	$2.40	$147.33 million	$148.35 million
1/27/2021	12/31/2020	$1.01	$0.86	($0.15)	$0.86	$152.63 million	$140.15 million
10/28/2020	9/30/2020	$0.77	$1.18	+$0.41	$1.18	$125.30 million	$142.84 million
7/29/2020	6/30/2020	$1.16	($11.37)	($12.53)	$12.89	$158.35 million	$117.63 million
5/19/2020	3/31/2020	$1.53	$1.42	($0.11)	$1.42	$168.25 million	$174.94 million
2/3/2020	Q3	$1.54	$1.76	+$0.22	$1.76	$172.00 million	$147.68 million
11/4/2019	Q2	$1.72	$1.46	($0.26)	$1.46	$168.60 million	$160.85 million
8/8/2019	Q1	$1.96	$1.72	($0.24)	$1.72	$169.80 million	$161.30 million
5/22/2019	Q4	$2.26	$1.52	($0.74)	$1.52	$189.90 million	$179.92 million

2/6/2019	Q3 2019	$1.95	$2.40	+$0.45	$2.40	$174.70 million	$176.38 million
11/5/2018	9/30/2018	$1.96	$1.60	($0.36)	$1.60	$167.40 million	$158.97 million
8/9/2018	6/30/2018	$2.33	$1.71	($0.62)	$1.71	$179.54 million	$154.62 million
5/17/2018	3/31/2018	$1.51	$2.17	+$0.66	$2.17	$166.59 million	$175.22 million
2/7/2018	Q3 2018		$1.37	+$1.37	$2.29		$155.46 million
11/7/2017	Q2 2018		$1.30	+$1.30	$1.30		$169.92 million
8/8/2017	Q1 2018		$1.35	+$1.35	$1.35		$161.32 million
5/22/2017	Q4		$2.05	+$2.05	$2.05		$196.41 million
2/9/2017	Q3 2017		$3.42	+$3.42	$3.42		$220.40 million
11/8/2016	Q2 2017		$3.00	+$3.00	$3.00		$228.79 million
8/10/2016	Q1 2017		$2.59	+$2.59	$2.59	$215.30 million	$233.80 million
5/26/2016	Q4 2016		$2.68	+$2.68	$2.68		$265.07 million
2/10/2016	Q3 2016		$4.41	+$4.41	$4.41	$974.38 million	$258.30 million
11/3/2015	Q2 2016		$3.11	+$3.11	$3.11		$212.06 million
8/6/2015	Q1 2016		$2.42	+$2.42	$2.42	$1.01 billion	$215.30 million
5/26/2015	Q4 2015		$3.56	+$3.56	$3.56	$881.79 million	$244.18 million
2/10/2015	Q3 2015		$3.33	+$3.33	$3.33	$213.60 million	$237.70 million
11/9/2014	Q2 2015		$3.35	+$3.35	$3.35		$250.83 million
8/7/2014	Q1 2015		$0.98	+$0.98	$0.88		$130.23 million
5/27/2014	Q4 2014		$2.10	+$2.10	$2.10	$165.13 million	$187.20 million
2/10/2014	Q3 2014		$2.59	+$2.59	$2.59	$185.70 million	$213.60 million
11/12/2013	Q2 2014		$2.15	+$2.15	$2.15		$205.32 million
8/7/2013	Q1 2014		$1.32	+$1.32	$1.32	$159.15 million	$153.20 million
5/23/2013	Q4 2013		$1.45	+$1.45	$1.80	$145.00 million	$165.10 million
2/4/2013	Q3 2013		$1.98	+$1.98	$1.98
11/1/2012	Q213		$1.46	+$1.46		$138.25 million	$160.97 million
8/6/2012	Q1 2013		$1.41	+$1.41	$1.41
5/24/2012	Q4 2012		$1.06	+$1.06	$1.06
2/10/2012	Q3 2012		$1.42	+$1.42	$1.44
11/10/2011	Q2 2012		$1.31	+$1.31	$1.30
7/26/2011	Q1 2012		$0.81	+$0.81	$0.82
5/26/2011	Q4 2011		$0.58	+$0.58	$0.58
1/28/2011	Q3 2011		$0.11	+$0.11	$0.11
10/29/2010	Q2 2011		$0.46	+$0.46	$0.46
8/23/2010	Q1 2011		$0.46	+$0.46	$0.46
6/14/2010	Q4 2010		$0.25	+$0.25	$0.25
12/2/2009	Q2 2010		$0.24	+$0.24	$0.24
8/10/2009	Q1 2010		$0.31	+$0.31	$0.31
5/22/2009	Q4 2009		$0.27	+$0.27	$0.27
2/10/2009	Q3 2009		$0.65	+$0.65	$0.85
11/11/2008	Q2 2009		$0.31	+$0.31	$0.31

(Earnings results data provided by Zacks Investment Research)

Taro Pharmaceutical Industries (NYSE:TARO) Earnings Frequently Asked Questions

When is Taro Pharmaceutical Industries's earnings date?: Taro Pharmaceutical Industries has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 27th, 2021 based off last year's report dates. Learn more on TARO's earnings history
Did Taro Pharmaceutical Industries beat their earnings estimates last quarter?: In the previous quarter, Taro Pharmaceutical Industries (NYSE:TARO) reported $1.09 earnings per share (EPS) to beat the analysts' consensus estimate of $0.84 by $0.25. Learn more on TARO's earnings details

How much revenue does Taro Pharmaceutical Industries generate each year?: Taro Pharmaceutical Industries (NYSE:TARO) has a recorded annual revenue of $548.97 million.
How much profit does Taro Pharmaceutical Industries generate each year?: Taro Pharmaceutical Industries (NYSE:TARO) has a recorded net income of -$386.65 million. TARO has generated $3.70 earnings per share over the last four quarters.
What is Taro Pharmaceutical Industries's price-to-earnings ratio?: Taro Pharmaceutical Industries (NYSE:TARO) has a trailing price-to-earnings ratio of 84.20 and a forward price-to-earnings ratio of 15.20.
What is Taro Pharmaceutical Industries's EPS forecast for next year?: Taro Pharmaceutical Industries's earnings are expected to grow from $4.21 per share to $4.55 per share in the next year, which is a 8.08% increase.

This page was last updated on 9/26/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.